Literature DB >> 10705302

Serum concentrations of granulocyte-colony stimulating factor in complicated Plasmodium falciparum malaria.

B Stoiser1, S Looareesuwan, F Thalhammer, F Daxböck, S Chullawichit, I El-Menyawi, W Graninger, H Burgmann.   

Abstract

Involvement of neutrophils in the control of blood parasites in malaria has been reported. Both, mononuclear phagocytes and neutrophils are known to be stimulated by cytokines such as TNF-alpha in order to augment the defence potency against the parasites. Previously, it has been shown that serum-G-CSF concentrations are increased in patients with bacterial sepsis. In vitro studies have shown that P. falciparum - infected erythrocytes induce the release of G-CSF by several cells such as endothelial cells and monocytes, however, nothing is known about G-CSF serum concentrations during the clinical course of severe P. falciparum malaria. Thus, it was the aim of the present study to investigate the time course for G-CSF serum concentrations in patients with complicated P. falciparum malaria, and to correlate these values with other mediators of inflammation and hematopoesis. Twenty-six patients suffering from complicated P. falciparum malaria were included in the study, and 20, age and sex matched, healthy volunteers were used as the negative control group. Serum samples for determination of G-CSF were taken on day 0, 7 and 14, and measured by ELISA. We found significantly increased serum concentrations of G-CSF in patients with complicated P. falciparum malaria on day 0, values decreasing to within the normal range by day 7. A significant correlation was found between G-CSF (d0) and procalcitonin, the parasite count, erythropoietin and macrophage inflammatory protein, however no correlation could be shown for the neutrophil count. In conclusion, on the day of hospital admission, elevated serum concentrations of G-CSF were detected in patients with complicated P. falciparum malaria, which might indicate a role of G-CSF in the acute defence mechanism against the parasites.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10705302

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  6 in total

1.  Distinct clinical and immunologic profiles in severe malarial anemia and cerebral malaria in Zambia.

Authors:  Philip E Thuma; Janneke van Dijk; Rick Bucala; Zufan Debebe; Sergei Nekhai; Thea Kuddo; Mehdi Nouraie; Günter Weiss; Victor R Gordeuk
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

2.  Neutrophil extracellular traps drive inflammatory pathogenesis in malaria.

Authors:  Sebastian Lorenz Knackstedt; Athina Georgiadou; Falko Apel; Ulrike Abu-Abed; Christopher A Moxon; Aubrey J Cunnington; Bärbel Raupach; Deirdre Cunningham; Jean Langhorne; Renate Krüger; Valentina Barrera; Simon P Harding; Aase Berg; Sam Patel; Kari Otterdal; Benjamin Mordmüller; Evelin Schwarzer; Volker Brinkmann; Arturo Zychlinsky; Borko Amulic
Journal:  Sci Immunol       Date:  2019-10-18

Review 3.  Severe malarial anemia: innate immunity and pathogenesis.

Authors:  Douglas J Perkins; Tom Were; Gregory C Davenport; Prakasha Kempaiah; James B Hittner; John Michael Ong'echa
Journal:  Int J Biol Sci       Date:  2011-11-02       Impact factor: 6.580

4.  Hypersplenism in liver disease and SLE revisited: current evidence supports an active rather than passive process.

Authors:  John M Gemery; Andrew R Forauer; Anne M Silas; Eric K Hoffer
Journal:  BMC Hematol       Date:  2016-02-09

Review 5.  Activation of stem cell up-regulation/mobilization: a cardiovascular risk in both mice and humans with implications for liver disease, psoriasis and SLE.

Authors:  John M Gemery; Andrew R Forauer; Eric K Hoffer
Journal:  Vasc Health Risk Manag       Date:  2019-08-26

Review 6.  Malarial pigment hemozoin and the innate inflammatory response.

Authors:  Martin Olivier; Kristin Van Den Ham; Marina Tiemi Shio; Fikregabrail Aberra Kassa; Sophie Fougeray
Journal:  Front Immunol       Date:  2014-02-05       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.